Gpt Healthcare Limited · NSE:GPTHEALTH
Gpt Healthcare — Q3 FY2025 Earnings Presentation
28 slides from Gpt Healthcare's earnings presentation, Feb 11, 2025
Slide 1: Exchange filing cover letter for investor presentation
GPT Healthcare Limited Regd. Office: GPT Centre, JC-25, Sector III, Salt Lake, Kolkata – 700 106, India CIN : L70101WB1989PLC047402 Phone : +91-33-4050-7000, Email : info@gptgroup.co.in , Visit us: www.gptgroup.co.in GPTHEALTH/CS/SE/2024-25 February 11, 2025 The Department of Corporate Services Nati
Slide 2: Investor Presentation – Q3 & 9MFY25
GPT Healthcare Limited Investor Presentation – Q3 & 9MFY25 N S E : G P T H E A LT H | B S E : 5 4 4 1 3 1
Slide 3: Safe Harbour
Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by GPT Healthcare Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any secur
Slide 4: Table of Content
Table of Content Q3 & 9MFY25 Company Overview Business Highlights Annual Financials Performance 3
Slide 5: Q3 & 9MFY25 Performance
Q3 & IMFY25 Performance \ = 7 \« LS " ¥ . \
Slide 6: Robust Performance Continues – Q3 & 9MFY25
Robust Performance Continues – Q3 & 9MFY25 Revenue from Operations EBITDA & EBIDTA Margin PAT & PAT Margin Rs 23.1 Cr Rs 12.2 Cr Q3FY25 Q3FY25 Q3FY25 Rs 102.2 Cr ( 22.2% Margin) ( 11.7% Margin) 4.1 YoY% 6.1 YoY% 5.8 YoY% Rs 69.6 Cr Rs 37.0 Cr 9MFY25 Rs 305.7 Cr 9MFY25 9MFY25 ( 22.3% Margin) ( 11.8%
Slide 7: Financial Highlights – 9MFY25
Financial Highlights – 9MFY25 Net Profit: Rs 37.0 Cr 53% Tax: Rs 15.9 Cr 23% 22% EBITDA : Depreciation: Rs 14.2 Cr 20% Rs 69.6 Cr Finance Costs Rs 2.5 Cr 4% Total Income : Medicines and Consumables: 24% 100% Rs 312.6 Cr Rs 58.8 Cr __% Employee Benefit Costs : Rs 55.0 Cr 23% Total Expenses: Rs 243.0
Slide 8: Hospital wise Performance – Q3 & 9MFY25
Hospital wise Performance – Q3 & 9MFY25 Bed Occupancy Rate ARPOB Year of Bed Capacity (%) (Rs Per day) Data as of Q1FY25 Commission (No. of Beds) Q3FY25 9MFY25 Q3FY25 9MFY25 57.6% 57.8% Salt Lake Hospital 2000 85 38,576 39,186 48.4% 47.4% Agartala Hospital 2011 205 33,563 32,812 67.9% 69.4% Dum Dum
Slide 9: Profit & Loss Highlights – Q3FY25
Profit & Loss Highlights – Q3FY25 Particulars (Rs Cr) Q3FY25 Q3FY24 YoY Q2FY25 QoQ 9MFY25 9MFY24 YoY Revenue from operations 102.2 96.6 5.8% 105.7 -3.3% 305.7 300.8 1.6% Other Income 1.9 1.2 58.3% 2.8 -32.1% 6.9 3.7 86.5% Total Income 104.1 97.8 6.4% 108.5 -4.1% 312.6 304.5 2.7% Cost of materials co
Slide 10: Growth Drivers in Place
Growth Drivers in Place Continued Investment in Infrastructure New Hospital ✓ Installed cutting-edge robotic surgical Existing Hospitals technology in Salt Lake and Howrah Hospital ✓ Setting up hospitals on Asset-light basis with over 480 robotic surgeries successfully where investment in land and b
Slide 11: Company Overview
Company Overview
Slide 12: Key regional corporate healthcare companies in Eastern India
GPT Healthcare – Key regional corporate healthcare companies in Eastern India ✓ Strategically located in Densely Populated Micro Markets of Kolkata and Howrah, and Agartala ✓ Established Right-Sized, Full-Service Hospitals according to each sub-region, aids High Return on Capital 561 90 560 4 NABH &
Slide 13: Salt Lake Hospital (Year 2000)
Salt Lake Hospital (Year 2000) Total 85 Beds, including 17 Beds across ICUs and HDUs along with 3 OTs The Department of Minimal Access Surgery is accredited by National Board of Examinations for training of post-graduate surgeons under the Fellowship of National Board in Minimal Access Surgery Award
Slide 14: Agartala Hospital (Year 2011)
Agartala Hospital (Year 2011) Total 205 Beds, including 66 Beds across ICUs along with 8 OTs & 1 catheterization laboratory The only NABH accredited hospital in Agartala and one among 11 valid accredited hospitals in North-East India as of October 2023. Also accredited by NABL Received the ‘Excellen
Slide 15: Dum Dum Hospital (Year 2013)
Dum Dum Hospital (Year 2013) Total 155 Beds, including 53 Beds across ICUs and HDUs along with 4 OTs & 1 catheterization laboratory NABH accredited and NABL accredited for complying with ISO 15189:2012 standards in the field of medical testing Recognized by the CII for Excellence in Nursing for thei
Slide 16: Howrah Hospital (Year 2019)
Howrah Hospital (Year 2019) Total 116 Beds, including 43 Beds across ICUs and HDUs along with 3 OTs & 1 catheterization laboratory Located in close proximity to the Howrah railway station and enjoys a strong locational advantage Recognized by the CII for Excellence in Nursing for their efforts, comm
Slide 17: New ILS Raipur Hospital – Commissioning Expected
New ILS Raipur Hospital – Commissioning Expected by March/Early April FY25 Quaternary Care State-of-the-art infrastructure for complex treatments and critical care Hospital Capacity 152 beds, including ICUs & HDUs, with Oncology facilities & Facilities Investment & Rs 55 Cr investment (~Rs 3.6 Mn pe
Slide 18: Business Highlights
Business Highlights
Slide 19: Focused on High Return on Capital – Factors that lead to it
Focused on High Return on Capital – Factors that lead to it Strategic Location Disciplined Approach Brand Strength Right Sized, towards Costs demonstrated through of the Hospitals Full Service Payor Mix Being in populous neighbourhoods Operating multispecialty, mid sized Strategic measures towards V
Slide 20: Professional and experienced leadership – Board of Directors
Professional and experienced leadership – Board of Directors Dwarika Prasad Tantia Dr. Om Tantia Anurag Tantia Dr. Aruna Tantia Dr. Ghanshyam Goyal Chairman & Wholetime Director Managing Director Whole-time Director Non - Executive Director Non - Executive Director C C M M M M M • Founding member of
Slide 21: Annual Performance
| Annual Performance
Slide 22: Key Financial Metrics
Key Financial Metrics Revenue from Operations (Rs Cr) EBITDA & EBIDTA Margin PAT & PAT Margin 23.0% 23.0% 12.2% 21.8% 22.7% 22.3% 400 11.8% 11.8% 361 11.5% 337 306 42 301 39 35 37 68 69.6 48 79 80 93 10.6% FY22 FY23 FY24 9MFY24 9MFY25 FY22 FY23 FY24 9MFY24 9MFY25 FY22 FY23 FY24 9MFY24 9MFY25 EBITDA
Slide 23: Key Operational Metrics
Key Operational Metrics No. of Beds & Occupancy Rate (%) Average Length of Stay (ALOS) Average Revenue per Occupied Bed (ARPOB) (in Rs per day) 36,671 59.7% 58.9% 58.9% 32,947 32,507 53.8% 4.80 556 561 561 561 561 4.22 3.95 3.98 56.4% 3.54 29,253 29,671 FY22 FY23 FY24 9MFY24 9MFY25 FY22 FY23 FY24 9M
Slide 24: Annual Profit & Loss
Annual Profit & Loss Particulars (Rs Cr) FY23 FY24 9MFY25 Revenue from operations 361.0 400.2 305.7 Other Income 5.7 5.3 6.9 Total Income 366.7 405.5 312.6 Cost of materials consumed 75.9 83.0 58.8 Employee benefits expense 62.0 68.9 55.0 Other expenses 148.8 160.5 129.2 EBITDA 80.0 93.1 69.6 EBITDA
Slide 25: Balance Sheet
Balance Sheet Assets (Rs Cr) Mar-23 Mar-24 Sep-24 Liabilities (Rs Cr) Mar-23 Mar-24 Sep-24 PPE 203.7 201.1 198.7 Share Capital 79.9 82.1 82.1 Other Equity 85.5 136.4 148.9 Other Non-Current Asset 36.6 45.1 55.4 Total Equity 165.4 218.5 231 Investments 5.2 19.2 22.9 Borrowings 40.3 3.6 2.3 Non-Curren
Slide 26: Cash Flow Statement
Cash Flow Statement Particulars (in Cr) Mar-23 Mar-24 Sep-24 Cash Flow from Operating Activities Profit before Tax 56.0 68.0 35.4 Adjustment from Non-Operating Items Operating Profit before Working Capital 74.6 90.0 44.1 (Increase)/decrease in Inventories -1.6 0.8 -0.9 (Increase)/decrease in Trade R
Slide 27: Stock Information
Stock Information Share Price Movement Shareholding Pattern (as on December-24) 250 25,000 29-Feb-2024 Public Listing Date 22,500 Promoters 18.9% 2nd Interim DII 65.6% Dividend of Re.1 /- 200 20,000 Final Dividend 10.8% of Rs. 1.5/- 17,500 FII 4.7% 150 15,000 Price in Rs 12,500 Volumes (in ‘000) 100
Slide 28: Thank You
Thank You GPT Healthcare Limited Stellar IR Advisors Pvt. Ltd. CIN No.: L70101WB1989PLC047402 Contact No.: 022 62398024 ghl.cosec@gptgroup.co.in Ms. Pooja Sharma pooja.sharma@stellar-ir.com For more details : www.ilshospitals.com Mr. Akhilesh Gandhi akhilesh@stellar-ir.com